134 related articles for article (PubMed ID: 36512828)
1. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
Ren L; Hua L; Bao Z; Deng J; Wang D; Chen J; Chen H; Juratli TA; Wakimoto H; Gong Y
J Neurooncol; 2023 Jan; 161(2):193-202. PubMed ID: 35612696
[TBL] [Abstract][Full Text] [Related]
6. Chordoid Meningioma: Differentiating a Rare World Health Organization Grade II Tumor from Other Meningioma Histologic Subtypes Using MRI.
Pond JB; Morgan TG; Hatanpaa KJ; Yetkin ZF; Mickey BE; Mendelsohn DB
AJNR Am J Neuroradiol; 2015 Jul; 36(7):1253-8. PubMed ID: 25882286
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
Ren L; Cheng H; Chen J; Deng J; Wang D; Xie Q; Wakimoto H; Hua L; Gong Y
J Neurosurg; 2023 Jul; 139(1):49-58. PubMed ID: 36334291
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features, Treatment, and Prognostic Factors of Chordoid Meningioma: Radiological and Pathological Features in 60 Cases of Chordoid Meningioma.
Yang Y; Li D; Cao XY; Hao SY; Wang L; Wu Z; Zhang JT
World Neurosurg; 2016 Sep; 93():198-207. PubMed ID: 27060511
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
10. WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors.
Ruzevick J; Gibson A; Tatman P; Emerson S; Ferreira M
J Clin Neurosci; 2021 Sep; 91():105-109. PubMed ID: 34373013
[TBL] [Abstract][Full Text] [Related]
11. Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes.
Khanna O; Fathi Kazerooni A; Arif S; Mahtabfar A; Momin AA; Andrews CE; Hafazalla K; Baldassari MP; Velagapudi L; Garcia JA; Sako C; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Flanders AE; Shi W; Davatzikos C
Neurosurg Focus; 2023 Jun; 54(6):E17. PubMed ID: 37552657
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
13. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
Kirches E; Sahm F; Korshunov A; Bluecher C; Waldt N; Kropf S; Schrimpf D; Sievers P; Stichel D; Schüller U; Schittenhelm J; Riemenschneider MJ; Karajannis MA; Perry A; Pietsch T; Boekhoff S; Capper D; Beck K; Paramasivam N; Schlesner M; Brastianos PK; Müller HL; Pfister SM; Mawrin C
Acta Neuropathol; 2021 Nov; 142(5):873-886. PubMed ID: 34495383
[TBL] [Abstract][Full Text] [Related]
15. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
17. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution.
Li P; Yang Z; Wang Z; Zhou Q; Li S; Wang X; Wang B; Zhao F; Liu P
Acta Neurochir (Wien); 2016 Jan; 158(1):67-76. PubMed ID: 26573513
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
